Sosnovik David E, Nahrendorf Matthias, Deliolanis Nikolaos, Novikov Mikhail, Aikawa Elena, Josephson Lee, Rosenzweig Anthony, Weissleder Ralph, Ntziachristos Vasilis
Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Circulation. 2007 Mar 20;115(11):1384-91. doi: 10.1161/CIRCULATIONAHA.106.663351. Epub 2007 Mar 5.
Fluorescence imaging of the heart is currently limited to invasive ex vivo or in vitro applications. We hypothesized that the adaptation of advanced transillumination and tomographic techniques would allow noninvasive fluorescence images of the heart to be acquired in vivo and be coregistered with in vivo cardiac magnetic resonance images.
The uptake of the magnetofluorescent nanoparticle CLIO-Cy5.5 by macrophages in infarcted myocardium was studied. Ligation of the left coronary artery was performed in 12 mice and sham surgery in 7. The mice were injected, 48 hours after surgery, with 3 to 20 mg of iron per kilogram of CLIO-Cy5.5. Magnetic resonance imaging and fluorescence molecular tomography were performed 48 hours later. An increase in magnetic resonance imaging contrast-to-noise ratio, indicative of myocardial probe accumulation, was seen in the anterolateral walls of the infarcted mice but not in the sham-operated mice (23.0+/-2.7 versus 5.43+/-2.4; P<0.01). Fluorescence intensity over the heart was also significantly greater in the fluorescence molecular tomography images of the infarcted mice (19.1+/-5.2 versus 5.3+/-1.4; P<0.05). The uptake of CLIO-Cy5.5 by macrophages infiltrating the infarcted myocardium was confirmed by fluorescence microscopy and immunohistochemistry.
Noninvasive imaging of myocardial macrophage infiltration has been shown to be possible by both fluorescence tomography and magnetic resonance imaging. This could be of significant value in both the research and clinical settings. The techniques developed could also be used to image other existing fluorescent and magnetofluorescent probes and could significantly expand the role of fluorescence imaging in the heart.
心脏的荧光成像目前仅限于侵入性的离体或体外应用。我们推测,采用先进的透照和断层扫描技术将能够在体内获取心脏的无创荧光图像,并使其与体内心脏磁共振图像进行配准。
研究了梗死心肌中巨噬细胞对磁荧光纳米颗粒CLIO-Cy5.5的摄取情况。对12只小鼠进行左冠状动脉结扎,7只进行假手术。术后48小时给小鼠注射每千克体重3至20毫克铁的CLIO-Cy5.5。48小时后进行磁共振成像和荧光分子断层扫描。梗死小鼠的前侧壁磁共振成像对比噪声比增加,表明心肌中有探针聚集,而假手术小鼠则未出现这种情况(23.0±2.7对5.43±2.4;P<0.01)。梗死小鼠的荧光分子断层扫描图像中心脏的荧光强度也显著更高(19.1±5.2对5.3±1.4;P<0.05)。通过荧光显微镜和免疫组织化学证实了梗死心肌中浸润的巨噬细胞摄取了CLIO-Cy5.5。
荧光断层扫描和磁共振成像均已证明可实现心肌巨噬细胞浸润的无创成像。这在研究和临床环境中可能具有重要价值。所开发的技术还可用于对其他现有的荧光和磁荧光探针进行成像,并可显著扩展荧光成像在心脏领域的作用。